Kitanotatsujin Corporation (2930.T)
JPY 143.0
(-2.07%)
JPY 143.0
(-2.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.65 Billion JPY | 3.8% |
| 2022 | 1.59 Billion JPY | 12.94% |
| 2021 | 1.4 Billion JPY | 37.87% |
| 2020 | 1.02 Billion JPY | -34.23% |
| 2019 | 1.55 Billion JPY | 19.75% |
| 2018 | 1.29 Billion JPY | 14.35% |
| 2017 | 1.13 Billion JPY | 52.43% |
| 2016 | 744.92 Million JPY | 262.49% |
| 2015 | 205.5 Million JPY | -51.21% |
| 2014 | 421.16 Million JPY | -17.79% |
| 2013 | 512.31 Million JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.27 Billion JPY | -3.82% |
| 2024 Q1 | 1.32 Billion JPY | -19.7% |
| 2023 FY | 1.65 Billion JPY | 3.8% |
| 2023 Q4 | 1.65 Billion JPY | 26.83% |
| 2023 Q3 | 1.3 Billion JPY | -25.83% |
| 2023 Q1 | 2.09 Billion JPY | 31.84% |
| 2023 Q2 | 1.75 Billion JPY | -16.3% |
| 2022 Q3 | 1.25 Billion JPY | 5.99% |
| 2022 Q1 | 1.02 Billion JPY | -27.59% |
| 2022 Q4 | 1.59 Billion JPY | 26.91% |
| 2022 FY | 1.59 Billion JPY | 12.94% |
| 2022 Q2 | 1.18 Billion JPY | 15.95% |
| 2021 Q4 | 1.4 Billion JPY | 23.69% |
| 2021 FY | 1.4 Billion JPY | 37.87% |
| 2021 Q1 | 1.27 Billion JPY | 24.23% |
| 2021 Q2 | 1.36 Billion JPY | 7.61% |
| 2021 Q3 | 1.13 Billion JPY | -16.62% |
| 2020 Q2 | 938.21 Million JPY | -6.99% |
| 2020 FY | 1.02 Billion JPY | -34.23% |
| 2020 Q4 | 1.02 Billion JPY | 35.85% |
| 2020 Q3 | 752.67 Million JPY | -19.78% |
| 2020 Q1 | 1 Billion JPY | -35.12% |
| 2019 Q1 | 987.73 Million JPY | -23.92% |
| 2019 FY | 1.55 Billion JPY | 19.75% |
| 2019 Q4 | 1.55 Billion JPY | 33.78% |
| 2019 Q3 | 1.16 Billion JPY | -3.39% |
| 2019 Q2 | 1.2 Billion JPY | 21.8% |
| 2018 Q2 | 1.15 Billion JPY | 18.56% |
| 2018 Q1 | 972.57 Million JPY | -14.34% |
| 2018 FY | 1.29 Billion JPY | 14.35% |
| 2018 Q4 | 1.29 Billion JPY | 17.18% |
| 2018 Q3 | 1.1 Billion JPY | -3.91% |
| 2017 Q1 | 714.4 Million JPY | -4.1% |
| 2017 Q4 | 1.13 Billion JPY | 18.22% |
| 2017 Q3 | 960.44 Million JPY | 4.72% |
| 2017 FY | 1.13 Billion JPY | 52.43% |
| 2017 Q2 | 917.19 Million JPY | 28.39% |
| 2016 Q2 | 261.97 Million JPY | 11.22% |
| 2016 Q4 | 744.92 Million JPY | 10.73% |
| 2016 Q3 | 672.72 Million JPY | 156.79% |
| 2016 Q1 | 235.54 Million JPY | 14.62% |
| 2016 FY | 744.92 Million JPY | 262.49% |
| 2015 Q3 | 240.29 Million JPY | -11.96% |
| 2015 Q4 | 205.5 Million JPY | -14.48% |
| 2015 Q2 | 272.93 Million JPY | -20.82% |
| 2015 Q1 | 344.71 Million JPY | -18.15% |
| 2015 FY | 205.5 Million JPY | -51.21% |
| 2014 FY | 421.16 Million JPY | -17.79% |
| 2014 Q2 | 476 Million JPY | 0.0% |
| 2014 Q4 | 421.16 Million JPY | -6.31% |
| 2014 Q3 | 449.54 Million JPY | -5.56% |
| 2013 FY | 512.31 Million JPY | 0.0% |
| 2013 Q4 | 512.31 Million JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Euglena Co., Ltd. | 37.92 Billion JPY | 95.642% |
| BEAUTY GARAGE Inc. | 6.49 Billion JPY | 74.544% |
| Axas Holdings Co.,Ltd. | 14.58 Billion JPY | 88.665% |
| C.I. Medical Co.,Ltd. | 21.36 Billion JPY | 92.265% |
| Kao Corporation | 757.7 Billion JPY | 99.782% |
| Niitaka Co., Ltd. | 9.35 Billion JPY | 82.336% |
| Rohto Pharmaceutical Co.,Ltd. | 99.13 Billion JPY | 98.333% |
| Shiseido Company, Limited | 615.1 Billion JPY | 99.731% |
| Lion Corporation | 188.22 Billion JPY | 99.122% |
| Mandom Corporation | 20.05 Billion JPY | 91.76% |
| Ivy Cosmetics Corporation | 1.32 Billion JPY | -24.564% |
| Milbon Co., Ltd. | 7.45 Billion JPY | 77.844% |
| Nippon Shikizai, Inc. | 13.56 Billion JPY | 87.812% |
| Fancl Corporation | 30.56 Billion JPY | 94.593% |
| KOSÉ Corporation | 88.61 Billion JPY | 98.135% |
| Cota Co., Ltd. | 3.85 Billion JPY | 57.102% |
| HABA Laboratories,Inc. | 3.92 Billion JPY | 57.883% |
| C'bon Cosmetics Co.,Ltd. | 3.14 Billion JPY | 47.514% |
| Pola Orbis Holdings Inc. | 33.26 Billion JPY | 95.031% |
| Noevir Holdings Co., Ltd. | 24.04 Billion JPY | 93.125% |
| Adjuvant Holdings Co.,Ltd. | 1.06 Billion JPY | -55.317% |
| Almado, Inc. | 1.94 Billion JPY | 15.088% |
| I-ne CO., LTD. | 8.57 Billion JPY | 80.733% |
| Premier Anti-Aging Co., Ltd. | 4.88 Billion JPY | 66.133% |
| Liberta Co.,Ltd. | 3.88 Billion JPY | 57.444% |
| AXXZIA Inc. | 2 Billion JPY | 17.63% |
| S.T. Corporation | 12.01 Billion JPY | 86.24% |
| Kobayashi Pharmaceutical Co., Ltd. | 62.65 Billion JPY | 97.362% |
| Earth Corporation | 60.4 Billion JPY | 97.264% |
| Sagami Rubber Industries Co., Ltd. | 7.79 Billion JPY | 78.807% |
| Asahi Eito Holdings Co.,Ltd. | 1.61 Billion JPY | -2.459% |
| Ya-Man Ltd. | 3.97 Billion JPY | 58.437% |
| MTG Co., Ltd. | 11.73 Billion JPY | 85.921% |
| TRANSACTION CO.,Ltd. | 4.17 Billion JPY | 60.386% |
| SHOBIDO Corporation | 8.89 Billion JPY | 81.425% |
| Artnature Inc. | 23.42 Billion JPY | 92.945% |
| Pigeon Corporation | 19.34 Billion JPY | 91.458% |
| Unicharm Corporation | 345.37 Billion JPY | 99.521% |
| Paltac Corporation | 222.34 Billion JPY | 99.257% |
| CB GROUP MANAGEMENT Co., Ltd. | 28.51 Billion JPY | 94.204% |